F. Bonnal

Infections sévères par le virus d'Epstein Barr

J. Ragnaud, J. Aubertin, F. Bonnal, 1982 .

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Prognostic factors of survival of HIV-infected patients with Cytomegalovirus disease: Aquitaine Cohort, 1986–1997

F. Dabis, M. Rougier, C. Binquet, 2000, European Journal of Epidemiology.

Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

F. Dabis, M. Rougier, C. Binquet, 2000, European journal of epidemiology.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study.

A. Mocroft, O. Kirk, A. Schultze, 2018, The Journal of infection.

Granulopénie et infection à Cytomégalovirus

J. Ragnaud, J. Aubertin, F. Bonnal, 1982 .